# TCGA-BRCA Pipeline for Dual CAR-NK Therapy



### A complete reproducible workflow for subtype-specific differential expression, surfaceome filtering and co-expression analysis



---



## üìå Overview



This repository contains a fully reproducible **R pipeline** developed to identify subtype-specific antigen pairs for potential **Dual-CAR NK cell targeting in breast cancer**.



The workflow integrates:



- TCGA-BRCA RNA-Seq (STAR-Counts)  

- PAM50 molecular subtypes  

- Differential expression (**DESeq2**)  

- Human Protein Atlas (**HPA**) surfaceome filtering  

- External GEO validation datasets  

- Pearson-based co-expression network construction  



**Goal:** Narrow down high-confidence co-expressed surface gene pairs that are highly expressed in tumor, low in normal tissues and subtype-specific.



---



## üî¨ Biological Background



Modern NK cell engineering uses CAR receptors targeting tumor antigens.  

However:



- Many breast cancer antigens are heterogeneous  

- Single target CAR therapy often fails due to antigen escape  

- Dual-CAR logic solves this by activating NK cells only when **two antigens are co-expressed** on the same tumor cell, improving specificity and reducing off-tumor toxicity  



This pipeline identifies a pair of co-expressed surface antigens for each BRCA subtype by combining **TCGA expression, HPA surface localization and correlation networks**.



---



## üéØ Objectives



- Identify Differentially Expressed Genes (DEGs) for each BRCA subtype vs normal tissue  

- Filter DEGs to surfaceome proteins using HPA Subcellular Data  

- Validate subtype-specific DEGs using independent GEO datasets  

- Construct co-expression networks and rank antigen pairs for dual-CAR NK targeting  



---



## üöÄ Complete Pipeline Steps



Each step below is fully reproducible and explained in beginner friendly manner.



### 1Ô∏è‚É£ Data Download ‚Äì TCGA-BRCA (STAR Counts)

- Use **TCGAbiolinks** to directly download raw count data from the GDC

- [GDC Data Transfer Tool v2.3.0](https://gdc.cancer.gov/access-data/gdc-data-transfer-tool) was used to get the raw data 

- Transcriptome Profiling ‚Üí Gene Expression Quantification ‚Üí STAR-Counts workflow  



**Outputs:**  

‚úî counts matrix (60660 genes √ó 1231 samples)  

‚úî sample_info metadata  

‚úî gene_info annotations  



**Why STAR-Counts?**  

Because STAR performs accurate alignment and TCGA uses it as the standardized pipeline.



---



### 2Ô∏è‚É£ Preprocessing & Cleaning

‚úî Keep only Primary Tumor + Solid Tissue Normal  

‚úî Standardize barcodes  

‚úî Remove gene versions (e.g., `ENSG000001.1 ‚Üí ENSG000001`)  

‚úî Filter for protein-coding genes  

‚úî Remove low-expressed genes  

‚úî Ensure meta and counts align perfectly  



**Output:**  

`results/01_preprocessed/sample_info_tumor_normal.csv`



---



### 3Ô∏è‚É£ Add PAM50 Subtypes

- Annotate samples with PAM50 subtypes: **LumA, LumB, Her2, Basal**  



**Output:**  

`results/02_metadata/TCGA_BRCA_metadata_final.csv`



---



### 4Ô∏è‚É£ Differential Expression (DESeq2)

For each subtype:  

**Tumor (that subtype) vs All Normals**



**Steps:**

- DESeq2 normalization  

- Wald test  

- Fold-change shrinkage (**ashr**)  

- Filter: `padj < 0.05 & |log2FC| ‚â• 1`  



**Outputs:**  

- `results/03_DESeq2_raw/`  

- `results/04_DESeq2_filtered/`  



---



### 5Ô∏è‚É£ VST Normalization & QC

‚úî Variance Stabilizing Transformation  

‚úî PCA plots to verify tumor vs normal separation  

‚úî Subtype clustering check  



**Output:**  

`results/QC/PCA_Condition_Subtype_manual.png`
![PCA after DESeq2](results/QC/PCA_Condition_Subtype_manual.png)


---



### 6Ô∏è‚É£ Gene Annotation

- Map **Ensembl IDs ‚Üí Gene Symbols**  

- Add Biotype information  



**Output:**  

`results/02_metadata/TCGA_gene_annotation.csv`



---



### 7Ô∏è‚É£ HPA Surfaceome Filtering

- Used **Human Protein Atlas v24.1 ‚Üí Subcellular Location data**  

- File `results/subcellular_location.tsv` downloaded from [Human Protein Atlas](https://www.proteinatlas.org/about/download)

- Filters:  

- MAIN LOCATION ‚àà {Plasma membrane, Cell Junctions, Primary Cilium, etc.}  

- RELIABILITY ‚â† Uncertain  

¬† - Filtered list  `results/hpa_filtered.csv`



**Rationale:**  

CAR receptors can target **only surface antigens** ‚Üí remove all non-surface DEGs.



---



### 8Ô∏è‚É£ GEO Validation (External Dataset)

- Validate each subtype using matched GEO dataset (LumA ‚Üí GSE86374, LumB ‚Üí GSE86374, HER2 ‚Üí GSE29431, Basal ‚Üí GSE86374)  

- Run GEO2R ‚Üí Extract DEGs ‚Üí Intersect with TCGA DEGs ‚Üí Intersect with surfaceome list  



**Output:**  

`results/HPA_intersected/`
`results/Venn diagrams/`


---



### 9Ô∏è‚É£ Prepare Clean VST Expression Matrix

‚úî Remove NA subtypes  

‚úî Correct subtype labels  

‚úî Merge annotation  

‚úî Collapse duplicate gene symbols  

‚úî Create clean `vsd_clean` matrix  



---



### üîü Co-Expression Analysis (Pearson)

**Goal:** Identify pairs of surface genes co-expressed in all the subtypes samples.  



Steps:

- Extract subtype expression  

- Keep only HPA-filtered surface genes  

- Compute Pearson correlation  

- Remove duplicates & self-pairs  

- Rank pairs  

- Filter: `|r| ‚â• 0.7`  



**Outputs:**  

- `results/07_coexpression`  

- `results/08_pairs`



---



## üìä Example Outputs

- Co-expression histogram ‚Üí `results/07_coexpression`  

- Top-ranked pairs (Dual-CAR candidates):  



| Gene1 | Gene2 | Correlation |
|-------|-------|-------------|
| X     | Y     | 0.93        |
| A     | B     | 0.90        |



---



## üß© Notes, Rationale & FAQ



### ‚ùì Why intersect TCGA with GEO

- TCGA alone may contain batch effects, patient-specific noise, subtype imbalance  

- GEO intersection ensures replication, subtype-specific signals and higher confidence  



### ‚ùì Why use HPA ‚ÄúSubcellular Location‚Äù

- CAR molecules target **surface-exposed antigens**  

- HPA MAIN LOCATION field provides experimentally verified plasma membrane, junctions, cilium domains  



### ‚ùì Why Pearson correlation

- TCGA VST-normalized data are continuous/parametric  

- Pearson captures linear co-expression  

- Widely used in TCGA/GTEx/WGCNA studies  



### ‚ùì Why subtype-wise DESeq2

- BRCA subtypes have distinct biology and antigenic profiles  

- Therapy must be subtype-optimized to avoid off-target toxicity  



### ‚ùì Why |LFC| ‚â• 1

- Ensures biologically meaningful regulation  

- Avoids noise from borderline DEGs  



### ‚ùì Why correlation threshold |r| ‚â• 0.7

- Strong biological co-expression  

- Reflects co-regulation probability  

- Standard in network biology  



---



## üìå How to Reproduce This Pipeline



```bash

# Clone the repository

git clone https://github.com/CH1NMAY117/TCGA-BRCA-pipeline

cd TCGA_BRCA



# Open the main file

Script.rmd



# Run all chunks sequentially in RStudio

```

